Dr. Michael D. Schwartz, MD
Critical Care Medicine (Critical Care Medicine (Internal Medicine) Physician)
- Medicare participating
At a glance
- Medical school
- University of California, Geffen School of Medicine (1987)
- Years since graduation
- 39
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 181
Licensed in Colorado since 1988, according to the Colorado Department of Regulatory Agencies. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1987Medical school: University of California, Geffen School of Medicine
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Critical Care Medicine (Internal Medicine) Physician primary
CO license 29047 (first issued 1988; active) -
Pulmonary Disease Physician
CO license 29047 (first issued 1988; active)
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- University of Colorado Hospital Authority Aurora, CO
- Saint Joseph Hospital Denver, CO
- Good Samaritan Medical Center LLC Lafayette, CO
- Intermountain Health Platte Valley Hospital Brighton, CO
- National Jewish Health Denver, CO
Medical groups
- National Jewish Health (247 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 181
- Services billed
- 431
- Patients’ average age
- 75
| Service | Times | Patients |
|---|---|---|
| Critical care, first 30-74 minutes | 204 | 92 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 108 | 70 |
| Established patient office or other outpatient visit, 40-54 minutes | 46 | 34 |
| Established patient office or other outpatient visit, 30-39 minutes | 42 | 33 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 33 | 33 |
| Test to examine how well the lungs exchange gases | 33 | 33 |
| Test to determine lung volumes using gas dilution or washout | 30 | 30 |
| Insertion of artery tube for blood sampling or infusion through skin | 14 | 14 |
| Critical care, each additional 30 minutes | 13 | 12 |
| New patient office or other outpatient visit, 60-74 minutes | 13 | 13 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Montelukast Sodium Other prescribers in Denver, CO | 105 |
| Azithromycin Other prescribers in Denver, CO | 60 |
| Breo Ellipta (fluticasone/vilanterol) Other prescribers in Denver, CO | 46 |
| Prednisone Other prescribers in Denver, CO | 36 |
| Albuterol Sulfate Hfa (albuterol sulfate) Other prescribers in Denver, CO | 26 |
| Omeprazole Other prescribers in Denver, CO | 26 |
| Anoro Ellipta (umeclidinium brm/vilanterol tr) Other prescribers in Denver, CO | 24 |
| Advair Hfa (fluticasone propion/salmeterol) Other prescribers in Denver, CO | 19 |
| Trelegy Ellipta (fluticasone/umeclidin/vilanter) Other prescribers in Denver, CO | 19 |
| Fluticasone Propionate Other prescribers in Denver, CO | 17 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 1 companies reported 1 payments worth $114 in total to this clinician.
| Verona Pharma, Inc. | $114 |
|---|
| Food and Beverage | $114 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.